Results 191 to 200 of about 242,337 (233)
Some of the next articles are maybe not open access.
Efficacy of topical cyclosporine for the treatment of ocular rosacea
Advances in Therapy, 2009This study was designed to compare the efficacy of cyclosporine ophthalmic emulsion 0.05% with an artificial tear solution for the treatment of rosacea-associated eyelid and corneal pathology.Double-masked, randomized, 3-month clinical trial of 37 patients with rosacea-associated eyelid and corneal changes (defined as lid margin telangiectasia ...
Barry A, Schechter +2 more
openaire +2 more sources
Successful treatment of phlyctenular keratoconjunctivitis with topical cyclosporin A
Contact Lens and Anterior Eye, 2013An 18-year-old Asian female presented with a 4 year history f recurrent discomfort, redness and photophobia in the left eye. here was no preceding trauma and she had no significant past edical history. There was no clinical or radiological evidence of uberculosis, sarcoidosis, Behc et’s disease and Rosacea.
Olugbemisola, Oworu +2 more
openaire +2 more sources
Topical Cyclosporine in High-risk Corneal Transplants
Ophthalmology, 1989Cyclosporine (cyclosporin A, CsA) is a selective T-cell immunosuppressant that works primarily through inhibition of both antigen presentation and lymphokine production. It has dramatically improved the prognosis for solid organ transplantation. Significant nephrotoxicity has been associated with its systemic use.
M W, Belin +3 more
openaire +2 more sources
Topical Cyclosporine as a Possible New Antimetabolite in Trabeculectomy
Ophthalmic Surgery, Lasers and Imaging Retina, 1996* BACKGROUND AND OBJECTIVE: The authors conducted a randomized, prospective, and controlled clinical and transmission electron microscopic study to investigate the possible role of cyclosporine in trabeculectomy as an antimetabolite agent. * PATIENTS AND METHODS: Twelve patients underwent trabeculectomy with topical cyclosporine and another ...
M E, Turaçli +3 more
openaire +2 more sources
Topical cyclosporin A in Thygeson's superficial punctate keratitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 1999Since September 1994 we have administered topical cyclosporin A 2% (CSA) in a prospective study to patients with Thygeson's superficial punctate keratitis (TSPK). After our promising short-term results we now present medium-term data of a larger patient group.Topical CSA was administered to 52 eyes of 28 patients with TSPK.
T, Reinhard, R, Sundmacher
openaire +2 more sources
Therapeutic use of topical cyclosporine.
Annals of ophthalmology, 1993Cyclosporine (cyclosporine A, CsA) is a selective immunosuppressant that inhibits T-cell activation. Its systemic use in the treatment of various ocular diseases has been successful. Topical CsA 2% was used in noncontrolled groups of seven patients with high-risk corneal transplants, two with peripheral corneal melting syndrome, three with chronic ...
G, Kaan, O, Ozden
openaire +1 more source
Topical cyclosporine administration in rabbits.
Research communications in chemical pathology and pharmacology, 1990Cyclosporine (CyA) is a potent immunosuppressant, but possesses toxicities which prohibit its unrestricted dosing in patients. The topical administration of CyA could serve to localize the immunosuppressive effect, or could serve as an administration route for patients who cannot tolerate the oral route of administration. We evaluated the potential for
L M, Stokar +4 more
openaire +1 more source
Topical Cyclosporine is Ineffective in the Treatment of Psoriasis
International Journal of Dermatology, 1992DELFINO, MARIO +2 more
openaire +3 more sources